Form 4: Arcutis Biotherapeutics Executive Sells Shares
Insider Transaction (Form 4)
Masaru Matsuda, See Remarks of Arcutis Biotherapeutics, Inc., sold 3,674 shares of common stock on September 16, 2026 for $25.00 per share.
Summary
- Open-market sale: disposed of 3,674 Common Stock at $25.00 ($91,853) on September 16, 2026; holds 112,508 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $91,853 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Masaru Matsuda — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 3,674 | $25 | $91.9K | 112,508 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (3,674 shares) |
Keywords
insider transaction, Form 4, ARQT, Arcutis Biotherapeutics, Inc., bearish, Masaru Matsuda
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.